ENSG00000178691 |
SUZ12 |
Endometrial Stromal Nodule |
gene_fusion |
100.0% (28/28) |
5 entries |
ENSG00000178691 |
SUZ12 |
hemangioblastoma |
sequence_alteration |
17.14% (6/35) |
1 entry |
ENSG00000178691 |
SUZ12 |
endometrial stromal sarcoma |
gene_fusion |
86.55% (103/119) |
9 entries |
ENSG00000178691 |
SUZ12 |
leiomyoma |
gene_fusion |
100.0% (4/4) |
1 entry |
ENSG00000178691 |
SUZ12 |
ovarian sex cord-stromal tumor |
gene_fusion |
100.0% (24/24) |
1 entry |
ENSG00000178691 |
SUZ12 |
breast ductal adenocarcinoma |
missense_variant |
2.086% (33/1582) |
1 entry |
ENSG00000178691 |
SUZ12 |
T-cell acute lymphoblastic leukemia |
stop_gained |
2.621% (26/992) |
2 entries |
ENSG00000178691 |
SUZ12 |
skin melanoma |
sequence_alteration |
0.9491% (11/1159) |
2 entries |
ENSG00000178691 |
SUZ12 |
bladder transitional cell carcinoma |
missense_variant |
0.8969% (4/446) |
2 entries |
ENSG00000178691 |
SUZ12 |
rectal adenocarcinoma |
sequence_alteration |
2.015% (11/546) |
1 entry |
ENSG00000178691 |
SUZ12 |
T-cell acute lymphoblastic leukemia |
frameshift_variant |
2.621% (26/992) |
4 entries |
ENSG00000178691 |
SUZ12 |
colon adenocarcinoma |
sequence_alteration |
1.04% (13/1250) |
1 entry |
ENSG00000178691 |
SUZ12 |
pancreatic ductal adenocarcinoma |
frameshift_variant |
1.308% (22/1682) |
1 entry |
ENSG00000178691 |
SUZ12 |
colorectal adenocarcinoma |
missense_variant |
1.993% (23/1154) |
3 entries |
ENSG00000178691 |
SUZ12 |
lung adenocarcinoma |
missense_variant |
0.4267% (11/2578) |
2 entries |
ENSG00000178691 |
SUZ12 |
skin melanoma |
missense_variant |
0.9491% (11/1159) |
2 entries |
ENSG00000178691 |
SUZ12 |
T-cell acute lymphoblastic leukemia |
missense_variant |
2.621% (26/992) |
3 entries |
ENSG00000178691 |
SUZ12 |
esophageal squamous cell carcinoma |
missense_variant |
0.8772% (6/684) |
3 entries |
ENSG00000178691 |
SUZ12 |
cecum adenocarcinoma |
missense_variant |
1.901% (5/263) |
2 entries |
ENSG00000178691 |
SUZ12 |
acute myeloid leukemia |
missense_variant |
0.7505% (8/1066) |
1 entry |
ENSG00000178691 |
SUZ12 |
myelodysplastic syndrome |
sequence_alteration |
2.083% (3/144) |
1 entry |
ENSG00000178691 |
SUZ12 |
cecum adenocarcinoma |
stop_gained |
1.901% (5/263) |
2 entries |
ENSG00000178691 |
SUZ12 |
colon adenocarcinoma |
missense_variant |
1.04% (13/1250) |
4 entries |
ENSG00000178691 |
SUZ12 |
breast carcinoma |
missense_variant |
0.7458% (11/1475) |
1 entry |
ENSG00000178691 |
SUZ12 |
basal cell carcinoma |
missense_variant |
8.824% (6/68) |
1 entry |
ENSG00000178691 |
SUZ12 |
Endometrial Endometrioid Adenocarcinoma |
missense_variant |
2.012% (13/646) |
1 entry |
ENSG00000178691 |
SUZ12 |
urothelial carcinoma |
missense_variant |
3.488% (3/86) |
1 entry |
ENSG00000178691 |
SUZ12 |
clear cell renal carcinoma |
sequence_alteration |
0.5054% (8/1583) |
1 entry |
ENSG00000178691 |
SUZ12 |
clear cell renal carcinoma |
missense_variant |
0.5054% (8/1583) |
2 entries |
ENSG00000178691 |
SUZ12 |
pancreatic ductal adenocarcinoma |
missense_variant |
1.308% (22/1682) |
1 entry |
ENSG00000178691 |
SUZ12 |
rectal adenocarcinoma |
missense_variant |
2.015% (11/546) |
5 entries |
ENSG00000178691 |
SUZ12 |
hepatocellular carcinoma |
missense_variant |
0.7114% (7/984) |
1 entry |
ENSG00000178691 |
SUZ12 |
T-cell acute lymphoblastic leukemia |
sequence_alteration |
2.621% (26/992) |
1 entry |
ENSG00000178691 |
SUZ12 |
squamous cell lung carcinoma |
missense_variant |
0.804% (8/995) |
1 entry |
ENSG00000178691 |
SUZ12 |
oral squamous cell carcinoma |
missense_variant |
0.7634% (2/262) |
2 entries |
ENSG00000178691 |
SUZ12 |
central nervous system primitive neuroectodermal neoplasm |
sequence_alteration |
0.6696% (3/448) |
1 entry |
ENSG00000178691 |
SUZ12 |
soft tissue sarcoma |
gene_fusion |
0.678% (2/295) |
1 entry |
ENSG00000178691 |
SUZ12 |
anaplastic astrocytoma |
missense_variant |
1.527% (2/131) |
1 entry |
ENSG00000178691 |
SUZ12 |
diffuse gastric adenocarcinoma |
sequence_alteration |
1.22% (1/82) |
1 entry |
ENSG00000178691 |
SUZ12 |
malignant peripheral nerve sheath tumor |
sequence_alteration |
15.38% (2/13) |
1 entry |
ENSG00000178691 |
SUZ12 |
Tonsillar Squamous Cell Carcinoma |
missense_variant |
11.11% (1/9) |
1 entry |
ENSG00000178691 |
SUZ12 |
head and neck squamous cell carcinoma |
missense_variant |
0.159% (1/629) |
1 entry |
ENSG00000178691 |
SUZ12 |
urothelial carcinoma |
frameshift_variant |
3.488% (3/86) |
1 entry |
ENSG00000178691 |
SUZ12 |
Merkel cell skin cancer |
stop_gained |
1.075% (1/93) |
1 entry |
ENSG00000178691 |
SUZ12 |
non-small cell lung carcinoma |
missense_variant |
0.9524% (1/105) |
1 entry |
ENSG00000178691 |
SUZ12 |
breast ductal adenocarcinoma |
stop_gained |
2.086% (33/1582) |
1 entry |
ENSG00000178691 |
SUZ12 |
Duodenal Adenocarcinoma |
missense_variant |
5.882% (1/17) |
1 entry |
ENSG00000178691 |
SUZ12 |
colon adenocarcinoma |
frameshift_variant |
1.04% (13/1250) |
1 entry |
ENSG00000178691 |
SUZ12 |
hairy cell leukemia |
frameshift_variant |
4.762% (1/21) |
1 entry |
ENSG00000178691 |
SUZ12 |
brain glioblastoma |
missense_variant |
0.165% (2/1212) |
1 entry |
ENSG00000178691 |
SUZ12 |
Gallbladder Adenocarcinoma |
missense_variant |
0.7246% (1/138) |
1 entry |
ENSG00000178691 |
SUZ12 |
lung adenocarcinoma |
sequence_alteration |
0.4267% (11/2578) |
1 entry |
ENSG00000178691 |
SUZ12 |
colon carcinoma |
missense_variant |
12.5% (1/8) |
1 entry |
ENSG00000178691 |
SUZ12 |
Primary Pulmonary Diffuse Large B-Cell Lymphoma |
missense_variant |
100.0% (1/1) |
1 entry |
ENSG00000178691 |
SUZ12 |
Mixed Lobular and Ductal Breast Carcinoma |
stop_gained |
1.667% (1/60) |
1 entry |
ENSG00000178691 |
SUZ12 |
bladder transitional cell carcinoma |
frameshift_variant |
0.8969% (4/446) |
1 entry |
ENSG00000178691 |
SUZ12 |
Anal Squamous Cell Carcinoma |
frameshift_variant |
1.22% (1/82) |
1 entry |
ENSG00000178691 |
SUZ12 |
gliosarcoma |
frameshift_variant |
9.091% (1/11) |
1 entry |
ENSG00000178691 |
SUZ12 |
polycythemia vera |
missense_variant |
1.25% (1/80) |
1 entry |
ENSG00000178691 |
SUZ12 |
large cell lung carcinoma |
frameshift_variant |
5.263% (1/19) |
1 entry |
ENSG00000178691 |
SUZ12 |
salivary gland squamous cell carcinoma |
missense_variant |
50.0% (1/2) |
1 entry |
ENSG00000178691 |
SUZ12 |
colon adenocarcinoma |
stop_gained |
1.04% (13/1250) |
1 entry |
ENSG00000178691 |
SUZ12 |
Olfactory Neuroblastoma |
missense_variant |
33.33% (1/3) |
1 entry |
ENSG00000178691 |
SUZ12 |
bladder transitional cell carcinoma |
stop_gained |
0.8969% (4/446) |
1 entry |
ENSG00000178691 |
SUZ12 |
bile duct adenocarcinoma |
missense_variant |
0.2597% (1/385) |
1 entry |
ENSG00000178691 |
SUZ12 |
angiosarcoma |
missense_variant |
2.128% (1/47) |
1 entry |
ENSG00000178691 |
SUZ12 |
lobular breast carcinoma |
missense_variant |
1.299% (3/231) |
1 entry |
ENSG00000178691 |
SUZ12 |
pharyngeal squamous cell carcinoma |
missense_variant |
1.235% (1/81) |
1 entry |
ENSG00000178691 |
SUZ12 |
colorectal adenocarcinoma |
stop_gained |
1.993% (23/1154) |
1 entry |
ENSG00000178691 |
SUZ12 |
myelodysplastic syndrome |
missense_variant |
2.083% (3/144) |
1 entry |
ENSG00000178691 |
SUZ12 |
T-cell acute lymphoblastic leukemia |
amino_acid_insertion |
2.621% (26/992) |
1 entry |
ENSG00000178691 |
SUZ12 |
skin melanoma |
conservative_inframe_deletion |
0.9491% (11/1159) |
1 entry |
ENSG00000178691 |
SUZ12 |
breast carcinoma |
gene_fusion |
0.7458% (11/1475) |
1 entry |
ENSG00000178691 |
SUZ12 |
breast carcinoma |
stop_gained |
0.7458% (11/1475) |
1 entry |
ENSG00000178691 |
SUZ12 |
urothelial carcinoma |
stop_gained |
3.488% (3/86) |
1 entry |
ENSG00000178691 |
SUZ12 |
Dermatofibrosarcoma protuberans |
sequence_alteration |
25.0% (1/4) |
1 entry |
ENSG00000178691 |
SUZ12 |
B-cell acute lymphoblastic leukemia |
missense_variant |
1.852% (1/54) |
1 entry |
ENSG00000178691 |
SUZ12 |
osteosarcoma |
missense_variant |
0.6579% (1/152) |
1 entry |
ENSG00000178691 |
SUZ12 |
solitary fibrous tumor |
sequence_alteration |
3.448% (1/29) |
1 entry |
ENSG00000178691 |
SUZ12 |
brain glioblastoma |
sequence_alteration |
0.165% (2/1212) |
1 entry |
ENSG00000178691 |
SUZ12 |
breast ductal adenocarcinoma |
conservative_inframe_deletion |
2.086% (33/1582) |
1 entry |
ENSG00000178691 |
SUZ12 |
gastric intestinal type adenocarcinoma |
missense_variant |
1.176% (1/85) |
1 entry |
ENSG00000178691 |
SUZ12 |
meningioma (disease) |
stop_gained |
1.389% (1/72) |
1 entry |
ENSG00000178691 |
SUZ12 |
small cell lung carcinoma |
missense_variant |
0.2242% (1/446) |
1 entry |
ENSG00000178691 |
SUZ12 |
glioma |
frameshift_variant |
0.3339% (2/599) |
1 entry |
ENSG00000178691 |
SUZ12 |
chronic myelomonocytic leukemia |
missense_variant |
1.205% (1/83) |
1 entry |
ENSG00000178691 |
SUZ12 |
malignant peripheral nerve sheath tumor |
stop_gained |
15.38% (2/13) |
1 entry |
ENSG00000178691 |
SUZ12 |
basal cell carcinoma |
sequence_alteration |
8.824% (6/68) |
1 entry |
ENSG00000178691 |
SUZ12 |
acute myeloid leukemia |
stop_gained |
0.7505% (8/1066) |
1 entry |